US Stock MarketDetailed Quotes

SANA Sana Biotechnology

Watchlist
  • 7.570
  • +0.070+0.93%
Trading Jun 3 13:10 ET
1.68BMarket Cap-4980P/E (TTM)

Sana Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
31.73%110.72M
7.55%293.14M
10.80%90.62M
-97.47%2.18M
59.51%116.29M
165.27%84.05M
-23.63%272.56M
-26.50%81.79M
3.30%86.19M
492.97%72.9M
Selling and administrative expenses
-2.96%16.27M
2.43%73.3M
-10.88%20.78M
23.65%19.18M
-9.44%16.57M
16.16%16.77M
41.96%71.56M
83.93%23.32M
15.49%15.51M
46.61%18.29M
-General and administrative expense
-2.96%16.27M
2.43%73.3M
-10.88%20.78M
23.65%19.18M
-9.44%16.57M
16.16%16.77M
41.96%71.56M
83.93%23.32M
15.49%15.51M
46.61%18.29M
Research and development costs
40.38%94.46M
9.37%219.84M
19.44%69.84M
-124.06%-17M
82.60%99.72M
290.04%67.29M
-34.42%201M
-40.70%58.47M
0.96%70.67M
276.00%54.61M
Operating profit
-31.73%-110.72M
-7.55%-293.14M
-10.80%-90.62M
97.47%-2.18M
-59.51%-116.29M
-165.27%-84.05M
23.63%-272.56M
26.50%-81.79M
-3.30%-86.19M
-492.97%-72.9M
Net non-operating interest income expense
53.54%3.03M
164.17%9.94M
69.00%2.73M
143.99%2.86M
272.68%2.37M
482.89%1.98M
456.51%3.76M
504.12%1.61M
642.41%1.17M
390.00%637K
Non-operating interest income
53.54%3.03M
164.17%9.94M
69.00%2.73M
143.99%2.86M
272.68%2.37M
482.89%1.98M
456.51%3.76M
504.12%1.61M
642.41%1.17M
390.00%637K
Other net income (expense)
557.45%215K
92.28%-52K
16.42%-224K
385.85%303K
57.58%-84K
53.92%-47K
-320.98%-674K
-195.37%-268K
-1,160.00%-106K
-19,900.00%-198K
Other non- operating income (expenses)
557.45%215K
92.28%-52K
16.42%-224K
385.85%303K
57.58%-84K
53.92%-47K
-320.98%-674K
-195.37%-268K
-1,160.00%-106K
-19,900.00%-198K
Income before tax
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
101.16%984K
-57.32%-114M
-161.14%-82.12M
24.29%-269.48M
27.35%-80.44M
-2.23%-85.12M
-487.87%-72.47M
Income tax
Net income
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
101.16%984K
-57.32%-114M
-161.14%-82.12M
24.29%-269.48M
27.35%-80.44M
-2.23%-85.12M
-487.87%-72.47M
Net income continuous Operations
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
101.16%984K
-57.32%-114M
-161.14%-82.12M
24.29%-269.48M
27.35%-80.44M
-2.23%-85.12M
-487.87%-72.47M
Minority interest income
Net income attributable to the parent company
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
101.16%984K
-57.32%-114M
-161.14%-82.12M
24.29%-269.48M
27.35%-80.44M
-2.23%-85.12M
-487.87%-72.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
101.16%984K
-57.32%-114M
-161.14%-82.12M
24.29%-269.48M
27.35%-80.44M
-2.23%-85.12M
-504.06%-72.47M
Basic earnings per share
-13.95%-0.49
-2.10%-1.46
-7.14%-0.45
101.11%0.005
-51.28%-0.59
-152.94%-0.43
33.18%-1.43
30.00%-0.42
2.17%-0.45
-490.00%-0.39
Diluted earnings per share
-13.95%-0.49
-2.10%-1.46
-7.14%-0.45
0
-51.28%-0.59
-152.94%-0.43
33.18%-1.43
30.00%-0.42
2.17%-0.45
-533.33%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 31.73%110.72M7.55%293.14M10.80%90.62M-97.47%2.18M59.51%116.29M165.27%84.05M-23.63%272.56M-26.50%81.79M3.30%86.19M492.97%72.9M
Selling and administrative expenses -2.96%16.27M2.43%73.3M-10.88%20.78M23.65%19.18M-9.44%16.57M16.16%16.77M41.96%71.56M83.93%23.32M15.49%15.51M46.61%18.29M
-General and administrative expense -2.96%16.27M2.43%73.3M-10.88%20.78M23.65%19.18M-9.44%16.57M16.16%16.77M41.96%71.56M83.93%23.32M15.49%15.51M46.61%18.29M
Research and development costs 40.38%94.46M9.37%219.84M19.44%69.84M-124.06%-17M82.60%99.72M290.04%67.29M-34.42%201M-40.70%58.47M0.96%70.67M276.00%54.61M
Operating profit -31.73%-110.72M-7.55%-293.14M-10.80%-90.62M97.47%-2.18M-59.51%-116.29M-165.27%-84.05M23.63%-272.56M26.50%-81.79M-3.30%-86.19M-492.97%-72.9M
Net non-operating interest income expense 53.54%3.03M164.17%9.94M69.00%2.73M143.99%2.86M272.68%2.37M482.89%1.98M456.51%3.76M504.12%1.61M642.41%1.17M390.00%637K
Non-operating interest income 53.54%3.03M164.17%9.94M69.00%2.73M143.99%2.86M272.68%2.37M482.89%1.98M456.51%3.76M504.12%1.61M642.41%1.17M390.00%637K
Other net income (expense) 557.45%215K92.28%-52K16.42%-224K385.85%303K57.58%-84K53.92%-47K-320.98%-674K-195.37%-268K-1,160.00%-106K-19,900.00%-198K
Other non- operating income (expenses) 557.45%215K92.28%-52K16.42%-224K385.85%303K57.58%-84K53.92%-47K-320.98%-674K-195.37%-268K-1,160.00%-106K-19,900.00%-198K
Income before tax -30.87%-107.48M-5.11%-283.26M-9.54%-88.12M101.16%984K-57.32%-114M-161.14%-82.12M24.29%-269.48M27.35%-80.44M-2.23%-85.12M-487.87%-72.47M
Income tax
Net income -30.87%-107.48M-5.11%-283.26M-9.54%-88.12M101.16%984K-57.32%-114M-161.14%-82.12M24.29%-269.48M27.35%-80.44M-2.23%-85.12M-487.87%-72.47M
Net income continuous Operations -30.87%-107.48M-5.11%-283.26M-9.54%-88.12M101.16%984K-57.32%-114M-161.14%-82.12M24.29%-269.48M27.35%-80.44M-2.23%-85.12M-487.87%-72.47M
Minority interest income
Net income attributable to the parent company -30.87%-107.48M-5.11%-283.26M-9.54%-88.12M101.16%984K-57.32%-114M-161.14%-82.12M24.29%-269.48M27.35%-80.44M-2.23%-85.12M-487.87%-72.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.87%-107.48M-5.11%-283.26M-9.54%-88.12M101.16%984K-57.32%-114M-161.14%-82.12M24.29%-269.48M27.35%-80.44M-2.23%-85.12M-504.06%-72.47M
Basic earnings per share -13.95%-0.49-2.10%-1.46-7.14%-0.45101.11%0.005-51.28%-0.59-152.94%-0.4333.18%-1.4330.00%-0.422.17%-0.45-490.00%-0.39
Diluted earnings per share -13.95%-0.49-2.10%-1.46-7.14%-0.450-51.28%-0.59-152.94%-0.4333.18%-1.4330.00%-0.422.17%-0.45-533.33%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg